Conversely, the PKC-δ-mediated activation of NFκB is often associated with tumor progression in pancreatic [9], hepatic [10] and breast [11,12,13] cancers as well as with HIV latency reversal in T cells [14,15]. Here, PRKCD is linked to cancer.